Search results for "Highlights"
More guideline-recommended diabetes care provided to older U.S. adults, not other age groups
From 2005 to 2018, the proportion of diabetes patients receiving care as recommended by the American Diabetes Association increased from 29.3% to 44.2% among those ages 65 years or older but did not change significantly for those ages 40 to 64 years (25.2% to 25.8%) or 20 to 39 years (9.9% to 26.0%).
https://diabetes.acponline.org/archives/2021/05/14/2.htm
14 May 2021
Meta-analysis quantifies survival gains from bariatric surgery
According to an analysis of studies of severely obese patients, metabolic-bariatric surgery was associated with median life expectancy gains of 9.3 years in patients with diabetes and 5.1 years in patients without diabetes.
https://diabetes.acponline.org/archives/2021/05/14/1.htm
14 May 2021
AHA issues policy statement on reducing lower-extremity amputations
Amputations among U.S. patients with diabetes decreased between 2000 and 2009 but increased by 50% from 2009 to 2015, leading the American Heart Association (AHA) to call for better identification and treatment of peripheral artery disease and propose policy solutions.
https://diabetes.acponline.org/archives/2021/04/09/3.htm
9 Apr 2021
GLP-1 receptor agonists, thiazolidinediones associated with lower risk of ischemic stroke
A recent meta-analysis from Denmark looked at patients with genetic variations that cause increases in plasma glucose levels and found that their elevated ischemic stroke risk appeared to be mitigated by treatment with certain classes of diabetes drugs.
https://diabetes.acponline.org/archives/2021/04/09/2.htm
9 Apr 2021
Task Force draft recommendation supports earlier diabetes screening
The draft recommendation calls for screening patients ages 35 to 70 years who are overweight or obese. It is open for public comment through Monday, April 12.
https://diabetes.acponline.org/archives/2021/04/09/1.htm
9 Apr 2021
No differences seen in outcomes with one-step vs. two-step gestational diabetes screening
The one-step screening process, which used a two-hour fasting glucose tolerance test, found more cases of gestational diabetes in a randomized trial, but perinatal and maternal complications did not differ.
https://diabetes.acponline.org/archives/2021/03/12/2.htm
12 Mar 2021
KDIGO made 12 recommendations for managing diabetes with CKD
The kidney group's guideline supports metformin and sodium–glucose cotransporter-2 inhibitors as first-line therapies for patients with chronic kidney disease (CKD) based on consistent trial data showing their effectiveness, noted an ACP Journal Club commentary.
https://diabetes.acponline.org/archives/2021/03/12/6.htm
12 Mar 2021
Exercise and CBT are cost-effective for diabetes patients with depression
A study used simulation modeling to project the long-term effects of a three-month exercise and cognitive behavioral therapy (CBT) intervention for patients with type 2 diabetes and major depressive disorder. It found clear cost-effectiveness with the interventions alone or combined.
https://diabetes.acponline.org/archives/2021/03/12/3.htm
12 Mar 2021
Incidence of diagnosed diabetes may be stable or declining in many countries
An analysis of 21 mostly high-income countries or jurisdictions found a downward or stable trend in clinically diagnosed diabetes incidence in recent years, but the drivers of these trends remain unknown, an accompanying editorial comment said.
https://diabetes.acponline.org/archives/2021/03/12/1.htm
12 Mar 2021
Choice of SGLT-2 inhibitors, GLP-1 receptor agonists should be based on individual risk
A meta-analysis comparing sodium-glucose cotransporter-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists found differing effects, including that the SGLT-2 inhibitors affected heart failure outcomes while GLP-1 receptor agonists reduced stroke risk.
https://diabetes.acponline.org/archives/2021/02/12/3.htm
12 Feb 2021